| 000 | 01176 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516053808.0 | ||
| 264 | 0 | _c20111230 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1744-8409 | ||
| 024 | 7 |
_a10.1586/eci.11.50 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGompels, Mark M | |
| 245 | 0 | 0 |
_aCinryze (C1-inhibitor) for the treatment of hereditary angioedema. _h[electronic resource] |
| 260 |
_bExpert review of clinical immunology _cSep 2011 |
||
| 300 |
_a569-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngioedemas, Hereditary _xprevention & control |
| 650 | 0 | 4 |
_aComplement C1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aComplement C1 Inactivator Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aComplement C1 Inhibitor Protein |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLock, Robert John | |
| 773 | 0 |
_tExpert review of clinical immunology _gvol. 7 _gno. 5 _gp. 569-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/eci.11.50 _zAvailable from publisher's website |
| 999 |
_c21136047 _d21136047 |
||